Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jr A Charles Rowland

Affiliations

  • Director at Nabriva Therapeutics Plc (NBRV), 2019-08-01
  • Director at Blueprint Medicines Corp (BPMC), 2019-06-25
  • Director at Viking Therapeutics Inc. (VKTX), 2019-01-04
  • Director at Nabriva Therapeutics Plc (NBRV), 2017-06-28
  • Director at Vitae Pharmaceuticals Inc (VTAE), 2016-10-25
  • Director at Dnib Unwind Inc. (BIND), 2016-08-30
  • Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
  • Vp, Chief Financial Officer at Viropharma Inc (VPHM), 2014-01-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NBRV $1.31 53,000 Director 53,000 2018-12-24 Filing
VKTX $5.16 30,000 Director 30,000 2018-05-29 Filing
VPHM $4.79 4,183 Officer 24,000 2009-02-26 Filing
VPHM $4.78 11,817 Officer 19,817 2009-02-26 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $94.83 9,271 Director 0 2019-06-20 Filing
BPMC $96.08 1,600 Director 9,271 2019-06-20 Filing
BPMC $96.69 947 Director 10,871 2019-06-20 Filing
VPHM $32.11 12,750 Officer 17,125 2012-03-01 Filing
VPHM $32.12 70,000 Officer 29,875 2012-03-01 Filing